Search
  • Site Search
  • News
  • Product
  • Zhejiang Medical Technology Development Co., Ltd.

    Common name

    Ambroxol Hydrochloride Injection

    Product name Mucosolvan®
    Common name

    Ambroxol Hydrochloride Injection

    Product manufacturer

    Boehringer Ingelheim Espana,S.A.

    Product approval

    H20150468

    Indication

    • It is suitable for acute and chronic lung diseases with abnormal secretion of sputum and poor sputum. For example, acute exacerbation of chronic bronchitis, wheezing bronchitis and expectorant treatment of bronchial asthma. 

    • Preventive treatment of pulmonary complications after surgery. 

    • Treatment of premature and neonatal infant respiratory distress syndrome (IRDS).

    Specification

    2ml:15mg

    Dosage

    Preventive treatment: 

    For adults and children aged over 12 years: 2-3 times a day, 1 ampoule each time, slow intravenous injection; 

    For severe cases, the dose can be increased to 2 ampoules each time. 

    For children aged 6-12: 2-3 times a day, 1 ampoule each time. 

    For children aged 2-6: tid, 1/2 ampoule each time. 

    For children aged under 2 years: bid, 1/2 ampoule each time. 

    All doses are injected intravenously and slowly. 

    Treatment of Infant Respiratory Distress Syndrome (IRDS): 

    Based on infant weight, the total daily dosage is 30mg/kg, and is given in 4 times. 

    The injector pump should be used for administration, and the intravenous injection time should be at least 5 minutes. 

    The injection can also be mixed with glucose, fructose, saline or Ringer's solution for intravenous drip. 

    This product (pH5.0) must not be mixed with other solutions whose pH is greater than 6.3, because the increase of pH will lead to the precipitation of Ambroxol free base. 


    3rd Floor, Weijian Health Industrial Park, No. 272 Huancheng East Road, Xiacheng District, Hangzhou, Zhejiang, China
    BD@winhealth.Hk (overseas)
    0571-8718 6358
    Copyright ©2019 - 2024 Zhejiang Medical Technology Development Co., Ltd.